The Feasibility of a Web-based Application to Monitor Home Blood Pressure
1 other identifier
interventional
20
1 country
1
Brief Summary
Control of hypertension remains one of the most important interventions available to clinicians to reduce risk of cardiovascular disease, kidney disease and stroke. Self-measured home blood pressure monitoring plus additional support has been shown to reduce blood pressure in adults with previously uncontrolled hypertension. Most previous studies have utilized healthcare personnel to facilitate communication of home blood pressure levels to physicians and did not provide methods to directly transmit self-measured blood home blood pressure levels to physicians via the electronic health record. Emerging technology now provides the ability for patient's to upload self-measured blood pressure levels into their own medical record which may eliminate the need for additional health personnel. This study will examine the feasibility, patient adherence and physician and patient perceptions of a web-based application which will facilitate direct input of self-measured home blood pressure levels and patient reported symptoms directly into the electronic health record with message alerts to the provider for hypertension management. Up to 10 Loyola primary care physicians and 20 of their respective patients age 50 years and older who have a smart phone device or home computer and have treated hypertension will be enrolled. The study will utilize the existing web-application called MyChart. MyChart is the name of the web-based application and it is not an acronym. Enrolled patients will download the existing MyChart web-based application on their smart phone device or home computer and will record home blood pressure measurements using their home blood pressure machine into their smart phone application. The MyChart application is available to all patients receiving care in the Loyola Health Care System. The blood pressure readings and patient reported symptoms will then be available for their physicians to review within the electronic health record. After using the web-based application for two months, both patients and physicians will be asked to participate in focus groups and interviews, respectively, to determine their perceptions and satisfaction with the web-based application. Data from this feasibility study may be used to guide a future clinical trial of hypertension management that examines the effectiveness of the MyChart web-based application for frequent blood pressure monitoring compared to standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started May 2017
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2017
CompletedFirst Posted
Study publicly available on registry
April 17, 2017
CompletedStudy Start
First participant enrolled
May 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedMarch 6, 2020
March 1, 2020
2.4 years
April 11, 2017
March 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
The total number of patients screened for the study
The total number of patients who were examined for study eligibility
30 days
The total number of patients who meet study eligibility
The total number of patients who are screened for the study and meet study eligibility
30 days
The total number of patients who provide written informed consent to participate in the study
The total number of patients who enroll in the study and provide written informed consent
30 days
The number of home blood pressure readings submitted by patients to the MyChart web-based application
The actual number of home blood pressure readings that are recorded in the electronic health record as submitted via MyChart
60 days
Change in systolic blood pressure
Change in systolic blood pressure
60 days
Change in diastolic blood pressure
Change in diastolic blood pressure
60 days
Physician actions based on home blood pressure readings
Total number of times a physician escalates or de-escalates blood pressure lowering medications for a study participant
60 days
Correlation between office and home blood pressure readings
Correlation between the office blood pressure measurement using the clinic Omron machine and the patient's home blood pressure cuff
one day
Adverse events
Total number of patient reported adverse events and all hospitalizations and emergency room visits
60 days
Patient reported outcomes
The percentage quality of life questionnaires completed by the study participants
60 days
Study Arms (1)
Intervention
OTHERIntervention is the use of the MyChart web-application whereby participants record their home blood pressure readings directly into their electronic medical record. Their physicians are then alerted of these blood pressure readings.
Interventions
Participants will record home blood pressure readings directly into the electronic health record via the MyChart application
Eligibility Criteria
You may qualify if:
- Willing to participate in all study procedures
- Potential subject owns a personal device and is able to run the web-application
- Physician directed blood pressure goal is \< 140/90 mmHg
You may not qualify if:
- No use of blood pressure lowering medications
- Arm circumference too large or small to allow accurate blood pressure measurement
- A medical condition likely to limit survival to less than 6 months, or a cancer diagnosed and treated within the past two years that, in the judgment of clinical study staff, would compromise a participant's ability to complete the study
- Inability to give informed consent
- History of systolic heart failure (ejection fraction \< 35%)
- History of stroke
- History of proteinuria ≥ 1 gram in a 24 hour urine collection or a random urine albumin/creatinine ratio ≥ 300 mg/g or a random urine protein/creatinine ratio ≥ 300 mg/g
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loyola University Medical Center
Maywood, Illinois, 60153, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Holly Kramer, MD MPH
Loyola University Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 11, 2017
First Posted
April 17, 2017
Study Start
May 16, 2017
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
March 6, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share